Navigation Links
India Developing Oral Vaccine to Fight Diabetes

India is on the threshold of launching an oral vaccine for diabetes that would replace the current practice of insulin injections, promising relief to millions in the country// suffering from the debilitating health condition.

The Andhra Pradesh-based pharmaceutical company Transgene Biotek Ltd is currently doing research and pre-clinical trials of the vaccine in collaboration with the Indian Institute of Chemical Technology (IICT), Hyderabad.

"We have made considerable progress in the drug development process. The new vaccine will be administered in liquid form," Prakash V. Diwan, chief of pharmacology of IICT, told IANS.

Diwan, however, said they would not like to divulge details about the development. "It's too early to give further details."

With nearly 40 million diabetes patients, India is home to over 20 percent of the total cases worldwide. Experts believe that given the changing lifestyles, the disease could take on an endemic status soon.

Health Minister Anbumani Ramadoss had told IANS earlier that pre-clinical trials of the oral vaccine were at an advanced stage and "by the second half of 2008 there will be some reason to smile".

The oral insulin vaccine has shown a reduction in blood glucose levels comparable to that of the injectable insulin, officials said. Once taken, the benefits would persist for almost 24 hours and help in better management of diabetes.

However, experts involved in the research said they would go for a "toxicological test" of the drug in "animal mammals because of the safety factor".

"The clinical trial will have two phases - in phase one the drug would be tested on animal mammals and on phase two on humans. Nearly 200 to 250 mammals of two separate categories would be put under the toxicological test," said a researcher associated with the new vaccine, requesting he not be named.

In the second phase, the drug would be tested on at least 20 hu
'"/>




Page: 1 2

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
Breaking Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6New lab test offers better prediction of HIV microbicide safety 9203 1New lab test offers better prediction of HIV microbicide safety 9203 2New lab test offers better prediction of HIV microbicide safety 9203 3Senesco Technologies Enters Into Agreement For Up To 241 0 Million In Financing 12970 1Senesco Technologies Enters Into Agreement For Up To 241 0 Million In Financing 12970 2Senesco Technologies Enters Into Agreement For Up To 241 0 Million In Financing 12970 3Senesco Technologies Enters Into Agreement For Up To 241 0 Million In Financing 12970 4Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress 51322 1Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress 51322 2Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress 51322 3